Healthcare entity
All 1 tracked stories fall under one category: market-trends. VITAS Healthcare is most often covered alongside Chemed Corporation, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4 for the same window.
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. VITAS Healthcare is most often covered alongside Chemed Corporation, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4 for the same window. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. VITAS Healthcare appears in 1 tracked Healthcare story from February 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering VITAS Healthcare. Shared-story counts are live from our verified record — not editorial picks.
Chemed Corporation and Zevia PBC both reported fourth-quarter 2025 revenue figures that fell short of Wall Street expectations, triggering significant stock price declines. Chemed, a major player in the hospice care sector through VITAS, saw its shares plummet 14.7% as investors reacted to the top-line disappointment.
Source: markets.financialcontent.com · markets.financialcontent.com
VITAS Healthcare is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
